Michelson Diagnostics appoints head of new US subsidiary
This article was originally published in Clinica
UK skin cancer imaging firm Michelson Diagnostics has appointed Karen Miller Gillis as vice-president of sales and marketing and general manager of its new US subsidiary in Massachusetts. Ms Gillis has 16 years' sales experience in the medtech industry; she was most recently with surgical products company Mpathy Medical Devices (which was acquired by Coloplast in October 2010) and prior to that, with retina scanner firm Optos. Ms Gillis joins Michelson as the company expands commercialisation of its VivoSight optical coherence tomography (OCT) scanner outside the UK. The device, which allows dermatologists to see up to 2mm below the surface of the patient's skin and improve diagnosis of skin cancer, was cleared by the US FDA in January last year (www.clinica.co.uk, 22 January 2010).
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.